CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.384
EU - Europa 2.508
AS - Asia 2.389
SA - Sud America 441
AF - Africa 291
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.020
Nazione #
US - Stati Uniti d'America 4.259
SG - Singapore 1.315
RU - Federazione Russa 1.150
CN - Cina 634
IT - Italia 477
BR - Brasile 376
IE - Irlanda 259
CI - Costa d'Avorio 189
VN - Vietnam 146
DE - Germania 143
UA - Ucraina 137
IN - India 100
FI - Finlandia 89
CA - Canada 82
GB - Regno Unito 59
KR - Corea 58
SN - Senegal 41
SE - Svezia 39
PL - Polonia 35
NL - Olanda 32
MX - Messico 31
AR - Argentina 24
HK - Hong Kong 24
BD - Bangladesh 20
NG - Nigeria 20
FR - Francia 19
ZA - Sudafrica 16
JP - Giappone 14
BE - Belgio 13
ES - Italia 12
ID - Indonesia 12
IQ - Iraq 12
CO - Colombia 11
EC - Ecuador 11
AT - Austria 10
TR - Turchia 9
BJ - Benin 8
CH - Svizzera 8
IR - Iran 7
PK - Pakistan 7
KE - Kenya 6
PY - Paraguay 6
AU - Australia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
VE - Venezuela 5
BG - Bulgaria 4
CL - Cile 4
LB - Libano 4
LT - Lituania 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
MY - Malesia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
IL - Israele 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MW - Malawi 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 10.020
Città #
Dallas 884
Singapore 780
Santa Clara 626
Moscow 517
Chandler 378
Dublin 258
Ashburn 221
San Jose 197
Abidjan 189
Los Angeles 186
Beijing 159
Chicago 156
Jacksonville 150
Hefei 135
Boardman 117
Catania 102
New York 93
Munich 89
Cambridge 64
Lawrence 64
Seoul 58
Civitanova Marche 56
Andover 55
Ho Chi Minh City 54
Helsinki 50
Buffalo 47
Kochi 47
São Paulo 46
Toronto 42
Dakar 41
Des Moines 35
Nanjing 34
Orem 31
Warsaw 31
Hanoi 28
Rome 26
Houston 25
Lappeenranta 25
Nanchang 25
Denver 24
Brooklyn 23
Hong Kong 23
Wilmington 22
Abuja 20
Montreal 20
The Dalles 20
Chennai 18
Columbus 18
Atlanta 17
Phoenix 17
Milan 16
Amsterdam 15
Boston 15
San Mateo 15
Mexico City 14
Modica 14
Palermo 14
Poplar 14
Stockholm 14
Brussels 13
Parma 13
Rio de Janeiro 13
Tokyo 13
Grafing 12
London 12
Mumbai 12
Philadelphia 12
Rende 12
Shenyang 12
Bremen 11
Changsha 11
Dong Ket 11
Jiaxing 11
Johannesburg 11
Milazzo 11
Tremestieri Etneo 11
Council Bluffs 10
Hebei 10
Ottawa 10
Lauterbourg 9
Saint Petersburg 9
Seattle 9
Cotonou 8
Tianjin 8
Turku 8
Charlotte 7
Manchester 7
Redwood City 7
San Francisco 7
Augusta 6
Bari 6
Brasília 6
Campinas 6
Fortaleza 6
Nairobi 6
New Delhi 6
Porto Alegre 6
Reggio Emilia 6
Curitiba 5
Erbil 5
Totale 6.848
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 319
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 151
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 145
[In Process Citation] 141
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 139
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 138
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 132
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 126
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 120
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 114
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 114
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 113
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 110
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 109
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 108
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 108
Anxiety disorders and adherence to HAART 106
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 106
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 106
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 103
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 102
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 99
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 99
Kidney disease in HIV-infected patients 98
Hepatic echinococcosis: clinical and therapeutic aspects 98
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 97
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 97
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 96
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 96
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 96
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 95
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 95
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 94
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 93
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 93
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 93
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 91
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 91
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 90
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 89
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 89
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 89
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 87
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 87
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 86
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 86
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 85
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 85
Serum tumor necrosis factor in acute and fulminant hepatitis B 84
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 84
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 84
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 83
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 83
Sifilide ed HIV.Presentazione di tre casi clinici 81
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 80
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 79
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 78
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 78
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 77
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 76
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 75
Microbial translocation in chronic liver diseases 74
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 73
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 73
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 72
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 72
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 72
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 71
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 71
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 69
Ageing with HIV: a multidisciplinary review 69
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 68
HCV and HIV infection among intravenous drug abusers in eastern Sicily 68
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 67
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 67
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 67
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 65
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 65
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 64
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 62
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 61
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 60
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 59
Sexual dysfunction in HIV plus subjects in eastern Sicily 59
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 59
Serum cytokines as predictors of clinical outcome in AIDS-related intestinal cryptosporidiosis 58
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 58
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 58
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 58
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 57
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 57
Factors associated with weight gain in people treated with dolutegravir 57
Prevalence of HLA-B*5701 and access to genetic test in Sicily. A multicenter study 56
New HIV diagnosis and linkage to care in two outpatient units in South Europe 56
Weight gain: A possible side effect of all antiretrovirals 55
Archi-Prevaleat project. A national register of color-doppler ultrasonography of the epi-aortic vessels in patients living with HIV 55
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 52
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial 51
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 50
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 50
Totale 8.681
Categoria #
all - tutte 34.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 0 29 0 35 24 52 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.032 71 67 14 101 106 171 5 177 242 5 40 33
2023/2024486 28 62 21 30 22 132 5 34 4 21 78 49
2024/20252.628 25 282 109 102 562 332 92 86 233 274 290 241
2025/20264.946 376 375 1.064 523 1.057 1.324 227 0 0 0 0 0
Totale 10.241